Prior work in human melanoma cell lines detected increased expression of CSPG4, also known as melanoma-associated chondroitin sulfate proteoglycan (MCSP) or neuron-glial antigen 2 (NG2), when ARSB activity was reduced. The gene discussed is ARSB; the disease is melanoma.